These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16571191)

  • 21. Innovations and productivity: an empirical investigation in Dutch hospital industry.
    Blank JL
    Adv Health Econ Health Serv Res; 2008; 18():89-109. PubMed ID: 19725358
    [No Abstract]   [Full Text] [Related]  

  • 22. Health technology assessment and public health: a time for convergence.
    Battista RN; Lafortune L
    Eur J Public Health; 2009 Jun; 19(3):227. PubMed ID: 19380330
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of health technology assessment in Lithuania.
    Danguole J
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary survey on the influence of rapid health technology assessments.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
    Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
    Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budgeting and health technology assessment: first evidence obtained from proposal forms used to submit the adoption of new technology.
    Lettieri E; Masella C; Nocco U
    Int J Technol Assess Health Care; 2008; 24(4):502-10. PubMed ID: 18828947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of strengths, weaknesses, opportunities, and threats in the development of a health technology assessment program in Turkey.
    Kahveci R; Meads C
    Int J Technol Assess Health Care; 2008; 24(2):235-40. PubMed ID: 18400128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Technology assessment and operating procedures for the technological resources in the new Community Health Service].
    Manzi P; Goletti M; Bossi A; Grasso P
    Clin Ter; 2002; 153(2):99-106. PubMed ID: 12078347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking evidence from health technology assessments to policy and decision making: the Alberta model.
    Borowski HZ; Brehaut J; Hailey D
    Int J Technol Assess Health Care; 2007; 23(2):155-61. PubMed ID: 17493300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. History of health technology assessment: Spain.
    Sampietro-Colom L; Asua J; Briones E; Gol J;
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():163-73. PubMed ID: 19538814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health technology assessment in Denmark: strategy, implementation, and developments.
    Sigmund H; Kristensen FB
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The process of decision-making in home-care case management: implications for the introduction of universal assessment and information technology.
    Egan M; Wells J; Byrne K; Jaglal S; Stolee P; Chesworth BM; Hillier LM
    Health Soc Care Community; 2009 Jul; 17(4):371-8. PubMed ID: 19187422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing external risks to health technology assessment programs.
    Hailey D; Juzwishin D
    Int J Technol Assess Health Care; 2006; 22(4):429-35. PubMed ID: 16984675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Health technology assessment of innovative medical devices: Timing and decision at national and local level].
    Pesqué R; Percheron R; Cordonnier AL; Steelandt J; Paubel P; Pineau J; Prognon P; Martelli N
    Ann Pharm Fr; 2020 Mar; 78(2):189-197. PubMed ID: 31806152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten arguments for a societal perspective in the economic evaluation of medical innovations.
    Jönsson B
    Eur J Health Econ; 2009 Oct; 10(4):357-9. PubMed ID: 19618224
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of health technology assessment in France.
    Weill C; Banta D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():108-11. PubMed ID: 19534838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Introduction of Health technology assessment at hospital].
    Boudard A; Cordonnier AL; Martelli N; Lechat P; Sinègre M; Pineau J
    Ann Pharm Fr; 2016 Nov; 74(6):473-481. PubMed ID: 27139164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.